187 results on '"Shen, Colette J"'
Search Results
2. Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients: A Multicenter Trial.
3. Target Delineation in Postoperative Radiation Therapy for Head and Neck Cancer After Flap Reconstruction
4. Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer Foundation
5. Biomarkers in Head and Neck Cancer
6. Prognostic and Predictive Clinical and Biological Factors in HPV Malignancies
7. Lymphoma
8. Anatomy and Target Delineation: Definitive and Postoperative Adjuvant Radiation Therapy in Vulvar Cancer
9. NTCP modeling and dose–volume correlations for acute xerostomia and dry eye after whole brain radiation
10. Assessing the Effectiveness of Systemic Therapy after Stereotactic Radiosurgery on Cancer Recurrence and All-Cause Mortality
11. Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
12. Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial
13. Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage
14. Abstract PR05: Changing the radiation and immune-oncology paradigm in patients with head and neck squamous cell carcinoma (HNSCC) with the radioenhancer NBTXR3: From bench to bedside
15. Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
16. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database
17. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring
18. Data from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
19. Supplementary Data from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
20. Supplementary figure 4: PFS and OS by ajcc8 from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
21. Supplementary Figure 1: B cell gating from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
22. Supplementary figure 3: Cytokines and Chemokines from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
23. Supplementary Figure 2: T cell gating from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
24. Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship
25. Socioeconomic factors affect the selection of proton radiation therapy for children
26. Adhesion Regulates MAP Kinase/Ternary Complex Factor Exchange to Control a Proliferative Transcriptional Switch
27. Decreased cell adhesion promotes angiogenesis in a Pyk2-dependent manner
28. Lymphoma
29. Bioactive hydrogels made from step-growth derived PEG–peptide macromers
30. The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies
31. Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma
32. Engineering amount of cell–cell contact demonstrates biphasic proliferative regulation through RhoA and the actin cytoskeleton
33. Patterning Cell and Tissue Function
34. Radiation therapy for infants with cancer
35. Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma
36. Common Error Pathways in CyberKnife™ Radiation Therapy
37. Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication
38. Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions
39. NANORAY-1100: A phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with anti-PD-1 therapy.
40. Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
41. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation
42. Prospective Assessment of Patient-Reported Dry Eye Syndrome After Whole Brain Radiation
43. PIK3CA mutation as a prognostic factor in HPV-associated oropharynx cancer.
44. Mature results of the LCCC1413 phase II trial of de-intensified chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma.
45. Antitumor immune response induced by NBTXR3 activated by radiotherapy.
46. Phase I study of durvalumab and tremelimumab together with radiotherapy for the adjuvant treatment of intermediate-risk head and neck squamous cell carcinoma.
47. Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy
48. Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose
49. Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma.
50. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.